Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Low Use of FDA ‐Approved Medications for Sickle Cell Disease in Adults
Low Use of FDA ‐Approved Medications for Sickle Cell Disease in Adults
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Joshua G. Rivenbark
,
Alan C. Kinlaw
,
Justin G. Trogdon
,
Jane A. Little
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
European Journal of Haematology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center
by: Jennifer A. Afranie‐Sakyi, et al.
Published: (2025)
Tebapivat Improves Red Cell Deformability and Decreases Sickling in Patients With Sickle Cell Disease: A Phase 1 Trial Substudy
by: Julia Z. Xu, et al.
Published: (2025)
Whole Blood Transcriptomic Analysis of Sickle Cell Trait
by: Mari Johnson, et al.
Published: (2026)
Real‐World Evidence of Crizanlizumab Showing Reductions in Vaso‐Occlusive Crises and Opioid Usage in Sickle Cell Disease
by: Laurie DeBonnett, et al.
Published: (2024)
Prevention and Management of Acute Chest Syndrome Without Automated Red Cell Exchange Among Patients With Sickle Cell Disease Not Requiring ICU Care: A Systematic Review and Network Meta‐Analysis
by: Mohammed Alsabri, et al.
Published: (2026)